➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Merck
McKesson
Dow
Baxter

Last Updated: September 25, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TWYNSTA

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Twynsta

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01243268 ↗ A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy Completed Boehringer Ingelheim N/A 2010-12-01 This is a prospective, observational, open-label, multi-center study, which will provide detailed information about the safety and efficacy of Twynsta tablets in Korean hypertensive patients requiring combination therapy. This will present a convenient treatment option for hypertension in Korean patients.
NCT01316419 ↗ Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension Completed Boehringer Ingelheim N/A 2011-03-01 This observational study is designed to evaluate the effects of Twynsta tablets with life style modifications on blood pressure, quality of life, and other risk factors in Korean patients with hypertension in a routine clinical practice setting.
NCT02387619 ↗ The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine Completed Jeil Pharmaceutical Co., Ltd. Phase 1 2015-02-01 A randomized, open-label, multiple-dose, crossover study to investigate the pharmacokinetic drug interaction between rosuvastatin and telmisartan/amlodipine in healthy male volunteers
NCT02496910 ↗ PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton Completed Yuhan Corporation Phase 1 2015-06-01 This is a Randomized, open-label, single-dose, 2-treatment, 2-period, 2-sequence crossover design.
NCT02734355 ↗ Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation Completed Research Institute for Complex Problems of Cardiovascular Diseases, Russia Phase 4 2015-11-01 The objective of the study was to estimate the efficacy of telmisartan and amlodipine combination on the restoration of left atrial mechanical function after atrial fibrillation catheter ablation.
NCT04158076 ↗ Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine Not yet recruiting Addpharma Inc. Phase 3 2019-11-30 The purpose of this study is to evaluate the efficacy and safety of co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine in patients with primary hypercholesterolemia and essential hypertension.
NCT04667624 ↗ Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers Completed Hanlim Pharm. Co., Ltd. Phase 1 2020-02-29 A randomized, open label, single dose, 2-sequence, 4-period, cross-over phase I clinical trial to compare and evaluate the safety and pharmacokinetics after oral administration of "LodienT tablet 80/2.5mg(telmisartan/s-amlodipine)" and "TWINSTA tablet 80/5mg(telmisartan/amlodipine)" in healthy adult volunteers.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Twynsta

Condition Name

Condition Name for Twynsta
Intervention Trials
Hypertension 6
Atrial Fibrillation 1
Hyperlipidemia 1
Hypercholesterolemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Twynsta
Intervention Trials
Hypertension 3
Hypercholesterolemia 1
Atrial Fibrillation 1
Hyperlipidemias 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Twynsta

Trials by Country

Trials by Country for Twynsta
Location Trials
Korea, Republic of 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Twynsta

Clinical Trial Phase

Clinical Trial Phase for Twynsta
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 1 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Twynsta
Clinical Trial Phase Trials
Completed 6
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Twynsta

Sponsor Name

Sponsor Name for Twynsta
Sponsor Trials
Boehringer Ingelheim 2
Hanlim Pharm. Co., Ltd. 1
Addpharma Inc. 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Twynsta
Sponsor Trials
Industry 6
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Colorcon
Moodys
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.